UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000026043
Receipt number	R000029919
Scientific Title	Phase 2 trial of TAS-102 plus bevacizumab in patients with advanced/recurrent colorectal cancer who had previously received on oxaliplatin, irinotecan and fluoropyrimidine
Date of disclosure of the study information	2017/02/20
Last modified on	2017/02/08 08:16:05

---